发明名称 |
Antibody-endostatin fusion protein and its variants |
摘要 |
Methods of inhibiting the growth of tumors comprising administering chimeric fusion molecules comprising endostatin mutants and all or a portion of anti-Her2 or anti-EGFR antibodies. |
申请公布号 |
US9611313(B2) |
申请公布日期 |
2017.04.04 |
申请号 |
US201414254333 |
申请日期 |
2014.04.16 |
申请人 |
UNIVERSITY OF MIAMI |
发明人 |
Shin Seung-Uon;Rosenblatt Joseph David;Morrison Sherie L. |
分类号 |
A61K39/385;C07K14/78;A61K45/06;G01N33/574;C07K16/28;C07K16/32;A61K31/00;A61K39/00;A61K38/00 |
主分类号 |
A61K39/385 |
代理机构 |
Marshall, Gerstein & Borun LLP |
代理人 |
Marshall, Gerstein & Borun LLP |
主权项 |
1. A method comprising the steps of:
a) obtaining a biopsy sample of a tumor from a subject; b) contacting the biopsy sample with a chimeric fusion molecule comprising an anti-tumor antigen binding domain from an anti-HER2 antibody or anti-EGFR antibody and at least one human endostatin protein or fragment thereof, wherein the at least one human endostatin protein or fragment thereof comprises a proline to alanine amino acid substitution at position 125 of human endostatin, and (c) detecting vasculogenic mimicry in the biopsy sample. |
地址 |
Miami FL US |